In an effort to better educate patients and empower them to take the next step toward visual freedom, Brinton Vision has released a new, comprehensive Vision Correction Comparison Chart. The chart ...
The expanded age indication is supported by results from a 3-year FDA clinical trial that included 629 eyes. The EVO ICL demonstrated “a strong safety profile” with no reported cases of pupillary ...
Brinton Vision, a leader in advanced vision correction procedures, has published a new resource titled “Can EVO ICL treat astigmatism?” to help patients and reporters better understand how this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results